Q1/2020 ended March 31, 2020 of the Company and its subsidiaries, as shown below: (Unit : Thousand Baht) Q1/2020 Q1/2019 Change %Change Revenue 212,967 236,732 (23,765) (10.04%) Gross profit margin
Acc.001/2563 February 24, 2020 To: The President The Stock Exchange of Thailand Subject: Management discussion and analysis (MD&A) for the Year 2019 Dear Sir, S. Khonkaen Foods Public Company Limited
to decreasing in selling and administration expenses and gain on change in fair value less cost of sale of biological assets. Page 3/…… - 3 - Financial Position Asset As of 30 June 2020, the company
of Thailand Rajthanee Hospital Public Company Limited (“the Company”) would like to clarify the operating results of the Company and its subsidiaries for the year ended December 31, 2017 which has been
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
. Operating Result Overall operating results of the company and its subsidiaries Q3/16 Q2/17 Q3/17 Change +/(-) 9M/16 9M/17 Change +/(-) (Unit: THB million) QoQ YoY 9M Operating revenue 5,176 5,459 4,243 (22
- 2019 Balance by Quarter Change Q3–19 Q2–19 Q3–18 Q3–19 VS Q2–19 Q3–19 VS Q3–18 (Million Baht: MB) (MB) % (MB) % Total Revenue 1,799.1 1,730.1 1,053.3 69.0 4.0 745.8 70.8 Total Operating Expenses 1,677.5
Operating Results of the Company in Q2/2020 Q2/18 Q2/19 1H/18 1H/19 Change +/(-) (THB million) YoY 1H Operating Revenue 312 144 (54%) 599 363 (39%) Gross Profit 201 79 (61%) 389 216 (44%) EBITDA 95 27 (72
School Name: สารสาสน์วิเทศศึกษา (Translation) Re: BOD.SET 029/2017 August 11, 2017 Subject: Clarification on the Change in operating results for year ended June 30, 2017 over 20% compared with the